BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
303112345
6789101112
13141516171819
20212223242526
27282930123
45678910

 Thursday, April 24, 2014
 Top Breaking News
AstraZeneca PLC (AZN) To Shed Around 5,000 Jobs By 2016     More...
Celgene Corporation (CELG) Antes Up $710 Million Upfront For Phase 3-Ready Crohn's Disease Drug     More...
Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round     More...
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round     More...
AstraZeneca PLC (AZN) Eyes Spin-Offs, Remains Mum On Pfizer Inc. (PFE)     More...
Hyperion Therapeutics Wagers Up To $570 Million On Andromeda Biotech To Beef Up Orphan Disease Pipeline     More...
Drugmaker Pharma Pac Lays Off Most Of Its Remaining Employees     More...
Alexion Pharmaceuticals Inc. (ALXN) CEO Racks Up $30 Million Salary In 2013     More...
Zogenix, Inc. (ZGNX) Unloads Sumavel® DosePro® To Endo For $85 Million Cash     More...
Startup CRISPR Therapeutics Nabs $25 Million Series A , Forms A World-Renowned Team Of Academics And Clinicians     More...
McKesson Pharmaceutical (MCK) Hiring 40 By Summer     More...
FDA Approves Janssen Biotech Inc. (JNJ)'s SYLVANT™ For Rare Castleman's Disease     More...
ContraFect Corporation Brings In Ex-Five Prime Therapeutics, Inc. (FPRX)'s Chief For Top Post     More...
Merck & Co., Inc. (MRK) Announces Positive Outcome Of 3b Study For Kuvan     More...
 Featured Stories
Man Who Co-Discovered HIV Reveals Why There Won’t Be A Cure For AIDS     More...
Should And Would Amgen (AMGN) Break Itself Up?     More...
Hips Don't Lie: Women With Wide Hips More Likely To Have A One Night Stand, University of Leeds Study     More...
Antibiotic-Resistant MRSA "Superbug" Found In U.S. Homes, Columbia University Medical Center Study     More...
Antimicrobial Ingredient In Health Products Spurs Growth Of Breast Cancer Cells, American Chemical Society Reveals     More...
Gene Therapy Reverses Loss Of Memory In Mice With Alzheimer's, Universitat Autònoma de Barcelona Study     More...
Not Just For Sex: Why The Y Chromosome Is Essential For Male Survival, Whitehead Institute Study     More...
Money May Carry 3,000 Different Types Of Bacteria, New York University Reveals     More...
 More News
Sunascen Therapeutics Gets FDA's Green Light For The New Over-The-Counter NAUS-EASE® Tablets     More...
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain     More...
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Provide An Update On FDA's Ongoing Review Of The NDA For Migraine Versafilm™ Product     More...
Durata Therapeutics, Inc.  (DRTX) Initiates Enrollment In A Phase 3b Study Of Dalvance™ In A 1500 Mg Single Dose     More...
Array BioPharma, Inc. (ARRY) Release: Binimetinib Continues To Advance In Clinical Development     More...
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: Phase 3 DECISION Trial Of NEXAVAR (Sorafenib) In Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory To Radioactive Iodine Published In The Lancet     More...
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia®     More...
Progenics Pharmaceuticals, Inc. (PGNX) Announces The Completion Of Enrollment Of Chemotherapy Naive Cohort In Phase 2 Trial Of PSMA ADC     More...
Phase 2 Study Of Selinexor (KPT-330) Initiated By Karyopharm Therapeutics (KPTI) In Patients With Advanced Gynecologic Malignancies (SIGN Study)     More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Pride-HD Study Enrolling Patients Globally To Further Evaluate Pridopidine For The Symptomatic Treatment Of Huntington’s Disease     More...
Vernalis PLC (VNLPY.PK): Promising Results Of Ph Ib/II POC Study In ADHD     More...
Cynapsus Therapeutics Announces Positive Results Of CTH-104 Clinical Study Of APL-130277 For Parkinson's Disease     More...
Alexion Pharmaceuticals Inc. (ALXN) Initiates Multinational Registration Trials Of Eculizumab As A Potential Treatment For Patients With Relapsing Neuromyelitis Optica (NMO) And Refractory Generalized Myasthenia Gravis (MG)     More...
Genpact To Acquire Leading Regulatory Affairs Company In Life Sciences     More...
Enzo Biochem (ENZ) Announces Settlement Agreement With Affymetrix (Santa Clara, California) (AFFX)     More...
Hydra Biosciences, Inc. And Boehringer Ingelheim Corporation Announce Worldwide Collaboration To Develop Small-Molecule Inhibitors For The Treatment Of Central Nervous System Diseases And Disorders     More...
Agendia BV Announces New Agreement With Daiichi Sankyo, Inc. (4568.t) To Support Oncology Drug Development     More...
Quintiles, Inc. (Q) And Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Comprehensive Clinical Development Partnership     More...
Medivation, Inc. (MDVN) Enters Into License Agreement With OncoFusion For Compounds Targeting Bromodomain Proteins     More...
Sinovac Biotech Ltd. (SVA) Receives Notification Of China Government Grant For EV71 Vaccine Project     More...
Epizyme (EPZM) Announces Notice Of Allowance For U.S. Patent Application Covering Methods Of Treatment For Cancers With EZH2 Inhibitors     More...
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement     More...
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent     More...
iBio, Inc. (IBIO) Receives Patent Allowance In China For Fusion Protein Compositions And Technology     More...
Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining As CFO/CBO To Lead U.S. Site     More...
Tauriga Sciences Inc. (TAUG) Aggregate Private Placement Proceeds Exceed $1,100,000 USD Priced At 6 Cents Per Share     More...
Immunomedics, Inc. (IMMU) Highlights Clinical Pipeline For Solid Cancer And Lupus Therapy At R & D Day     More...
Crown Bioscience, Inc. Passes 1000 Model Mark In PDX Collection For Oncology Drug Discovery     More...
Active Biotech AB (BTPC) Interim Report January - March 2014     More...
Oriola-KD Corporation's Interim Report For 1 January-31 March 2014     More...
Mesa Labs (MLAB) Declares Quarterly Dividend     More...
Axxess Pharma, Inc. Is Pleased To Announce Amazon.com Has Sold Out Initial TapouT Order And Placed Second Order For The Company's TapouT Pain Relief Line     More...
Novartis AG (NVS) And Anne Geddes Launch Global Ebook Showcasing Meningococcal Survivors On World Meningitis Day     More...
Easton Pharmaceuticals (OP: EAPH) Receives Final Changes And Nears Completion On Its Reg. A SEC Filing To Raise Up To $5,000,000 In Additional Committed Financing     More...
NuGEN Technologies, Inc.’s Novel Technology For RNA-Seq Extends To A Broad Range Of Transcript Species     More...
Sarepta Therapeutics (SRPT) Announces Pricing Of $100.7 Million Public Offering Of Common Stock     More...
Sinequa Chosen By AstraZeneca PLC (AZN) To Support Worldwide R&D     More...
Liventa Bioscience Responds To Lawsuit     More...
U.S. District Court Finds In Favor Of Azbil BioVigilant, Inc. In Patent Litigation Dispute     More...
Array BioPharma, Inc. (ARRY) To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014     More...
Alkermes plc (ALKS) To Host Conference Call To Discuss First Quarter 2014 Financial Results     More...
Alexion Pharmaceuticals Inc. (ALXN) Reports First Quarter 2014 Results     More...
AmerisourceBergen Corporation (ABC) Reports Second Quarter Fiscal Year 2014 Results     More...
AMAG Pharmaceuticals, Inc. (AMAG) Announces First Quarter 2014 Financial Results     More...
Celgene Corporation (CELG) Reports First Quarter 2014 Operating And Financial Results     More...
Eli Lilly and Company (LLY) Reports First-Quarter 2014 Results     More...
Fluidigm Corporation To Announce Q1 2014 Financial Results And Host Conference Call For Investors     More...
Infinity Pharmaceuticals Inc. (INFI) Announces The Date Of Its First Quarter 2014 Financial Results Conference Call And Webcast     More...
Meridian Bioscience, Inc. (VIVO) Reports Second Quarter 2014 Operating Results And Revises Fiscal 2014 Guidance     More...
Lonza Inc. Q1 Business Performance On Track     More...
Oncothyreon Inc. (ONTY) Announces First Quarter 2014 Financial Results Conference Call     More...
Omnicell To Release First Quarter 2014 Earnings Results On May 1     More...
Pfizer Inc. (PFE) Hosts Annual Meeting Of Shareholders Declares 26-Cent Second-Quarter 2014 Dividend     More...
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) To Report First Quarter Financial Results On April 28, 2014     More...
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted Eps Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted Eps Guidance Of $4.30 To $4.40     More...
Salix Pharmaceuticals, Ltd. (SLXP) Announces 1Q2014 Financial Results Conference Call And Webcast     More...
The Medicines Company (MDCO) Reports First Quarter 2014 Financial Results     More...
Valeant Pharmaceuticals International (VRX) To Announce 2014 First Quarter Results On May 8, 2014     More...
Lupin Ltd. (LUPN.BO) Appoints Theresa Stevens As Chief Corporate Development Officer     More...
ContraVir Strengthens Its Board Of Directors With The Addition Of Virology Expert, Scientist, And Entrepreneur, Timothy M. Block, Ph.D.     More...
Veteran Life Sciences Advisor Selected Managing Director For Global Compliance Consulting Firm, Maetrics     More...
Pivotal Therapeutics Inc. Announces Resignation Of Directors     More...
Mettler-Toledo (MTD) Release: New Buyer's Guide Explains Dimensioning, Weighing And Scanning Solutions And Offers Guidance For Purchasing One     More...
Galena Biopharma  (GALE) Research Pioneer Presented With 2014 Award For Excellence In Technology Transfer     More...
Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Named One Of TIME Magazine’s 100 Most Influential People In The World     More...
Genocea Biosciences Co-Founder Receives TIME Magazine’s TIME 100 Honor     More...
OvaScience (OVAS) Co-Founder David Sinclair, Ph.D., Selected By TIME As One Of The 100 Most Influential People In The World     More...
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)     More...
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In May     More...
Celsion Corporation (CLN) Announces Updated Overall Survival Results from the HEAT Study of ThermoDox® in Primary Liver Cancer Presented at ECIO 2014     More...
Alcobra (ADHD) To Present New Data For Metadoxine Extended Release (MDX) At Upcoming Meetings     More...
Echo Therapeutics (ECTE) Files Preliminary Proxy Materials In Connection With 2014 Annual Meeting Of Stockholders     More...
PTC Therapeutics, Inc. (PTCT) To Present At Upcoming Investor Conferences     More...
NovaBay Pharmaceuticals, Inc. (NBY)' Neutrophase Is Focus Of Dr. John Crew's Presentation At Advanced Wound Care Symposium     More...
Antares Pharma, Inc. (ATRS) To Present At The Deutsche Bank (DB) 39th Annual Health Care Conference     More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At RedChip Global Online CEO Conference April 24     More...
BioInvent (BOVNF) Annual General Meeting     More...
CytRx Corporation (CYTR) Announces Global Phase 2b Trial Of Aldoxorubicin In Soft Tissue Sarcomas Selected For Oral Presentation At The 2014 American Society of Clinical Oncology Annual Meeting     More...
PerkinElmer, Inc. (PKI) To Present At Robert W. Baird & Co. 2014 Growth Stock Conference     More...
BioTime (BTX) To Present At GTC Stem Cell Summit 2014     More...
Advaxis, Inc. To Present At 2014 American Society of Clinical Oncology Annual Meeting     More...

 

//-->